Parametric Portfolio Associates’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Parametric Portfolio Associates’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-18,170	Closed	-$42K	–	4031
2019 Q1	$42K	Buy	18,170 +2,417	+15%	+$6.55K	﹤0.01%	3894
2018 Q4	$37K	Buy	+15,753	New	+$139K	﹤0.01%	3867
2018 Q2	–	Sell	-10,197	Closed	-$191K	–	4009
2018 Q1	$191K	Sell	10,197 -1,399	-12%	-$24.5K	﹤0.01%	3771
2017 Q4	$210K	Buy	+11,596	New	+$245K	﹤0.01%	3734

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parametric Portfolio Associates's SNNA Position: Q2 2019 in Review

Parametric Portfolio Associates sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q2 2019, closing a stake of 18,170 shares — an estimated $42K sold.

Parametric Portfolio Associates first reported a position in SNNA in Q4 2017 and held it in 4 quarters. The position peaked at $210K in Q4 2017. 48 funds tracked by Wall St. Rank hold SNNA as of Q2 2019.

Parametric Portfolio Associates reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Parametric Portfolio Associates sold 18,170 Sienna Biopharmaceuticals, Inc. shares in Q2 2019, an estimated $42K.
Parametric Portfolio Associates first reported a position in Sienna Biopharmaceuticals, Inc. in Q4 2017 and held it in 4 quarters.
Parametric Portfolio Associates's Sienna Biopharmaceuticals, Inc. position peaked at $210K in Q4 2017.
48 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q2 2019.

Based on Parametric Portfolio Associates's 13F filing for Q2 2019, filed 13 Aug 2019.